2020 IADR/AADR/CADR GENERAL SESSIONThe 98th General Session & Exhibition of the IADR was to be held in conjunction with the 49th Annual Meeting of the American Association for Dental Research and the 44th Annual Meeting of the Canadian Association for Dental Research, from March 18-21, 2020 in Washington, D.C., USA. Due to COVID 19 and the world pandemic, the meeting had to be canceled, but we were able to collect some of the science that was planned for presentation to be available to our members as part of an on demand meeting.
The recordings in this library are a selection of the science that was to be presented onsite at the General Session. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers, IADR Centennial Plenaries and symposia from a collection of scientific groups and networks.
This session can be purchased as part of the full meeting recordings within the product bundles
SESSION DESCRIPTIONIn the era of personalized medicine, it is desirable to have noninvasive or minimally invasive methods to determine and follow longitudinally the molecular composition of a patient’s tumor, which will help gain a broader molecular understanding of the disease. One such approach is through liquid biopsy that can be used to molecularly characterize the tumor and monitor genetic changes in the tumor over time using repeat sampling of biofluids. While most of the research on liquid biopsies use blood, other biofluids particularly saliva is emerging to be of translational and clinical utilities for oral and systemic diseases detection. Liquid biopsies have the potential to help clinicians screen for disease, stratify patients to the best treatment, monitor treatment response, and development of resistance. Liquid biopsy also offers an opportunity to detect early lesions and monitor recurrence in cases where biopsy is difficult, such as brain cancer. Recently, it has been shown that circulating tumor DNA (ctDNA) can also be found in saliva and can be useful in diagnosis of lung tumors. A panel of stellar researchers, pathologists and clinicians in the field of liquid biopsy research will address the above challenges, update on current knowledge, future research directions and potential clinical applications.
Organizer/Chair: Carmem Pfeifer, DDS, PhD – Oregon Health & Science University
Organizer/Chair: Marco Brotto – University of Texas at Arlington
- What is Liquid Biopsy?
- The Promises of liquid biopsy
- Liquid Biopsy and Dentistry